27.89
price down icon0.59%   -0.195
 
loading
Moderna Inc stock is traded at $27.89, with a volume of 2.98M. It is down -0.59% in the last 24 hours and down -10.67% over the past month. Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 40 mRNA development candidates in clinical development as of September 2024. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
See More
Previous Close:
$28.09
Open:
$28.15
24h Volume:
2.98M
Relative Volume:
0.29
Market Cap:
$10.85B
Revenue:
$3.14B
Net Income/Loss:
$-3.36B
P/E Ratio:
-3.1953
EPS:
-8.73
Net Cash Flow:
$-4.03B
1W Performance:
+8.83%
1M Performance:
-10.67%
6M Performance:
-22.21%
1Y Performance:
-68.96%
1-Day Range:
Value
$27.62
$28.30
1-Week Range:
Value
$25.79
$28.59
52-Week Range:
Value
$23.15
$89.80

Moderna Inc Stock (MRNA) Company Profile

Name
Name
Moderna Inc
Name
Phone
(617) 714-6500
Name
Address
325 BINNEY STREET, CAMBRIDGE
Name
Employee
5,800
Name
Twitter
@moderna_tx
Name
Next Earnings Date
2025-08-01
Name
Latest SEC Filings
Name
MRNA's Discussions on Twitter

Compare MRNA with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MRNA
Moderna Inc
27.89 10.90B 3.14B -3.36B -4.03B -8.73
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
394.19 100.71B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
577.43 61.52B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
458.97 58.84B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
657.54 40.01B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
315.28 38.20B 3.81B -644.79M -669.77M -6.24

Moderna Inc Stock (MRNA) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-13-25 Initiated Citigroup Neutral
Feb-18-25 Downgrade Barclays Overweight → Equal Weight
Jan-29-25 Downgrade Goldman Buy → Neutral
Dec-18-24 Downgrade Argus Buy → Hold
Dec-10-24 Resumed BofA Securities Underperform
Nov-19-24 Initiated Berenberg Hold
Nov-18-24 Upgrade HSBC Securities Hold → Buy
Nov-15-24 Initiated Wolfe Research Underperform
Oct-17-24 Initiated Bernstein Mkt Perform
Sep-13-24 Downgrade JP Morgan Neutral → Underweight
Sep-13-24 Downgrade Jefferies Buy → Hold
Sep-13-24 Downgrade Oppenheimer Outperform → Perform
Aug-28-24 Upgrade HSBC Securities Reduce → Hold
Aug-07-24 Upgrade Deutsche Bank Sell → Hold
Aug-05-24 Downgrade RBC Capital Mkts Outperform → Sector Perform
Feb-26-24 Downgrade HSBC Securities Hold → Reduce
Jan-02-24 Upgrade Oppenheimer Perform → Outperform
Nov-29-23 Initiated Canaccord Genuity Hold
Nov-03-23 Upgrade HSBC Securities Reduce → Hold
Nov-02-23 Downgrade Deutsche Bank Hold → Sell
Aug-04-23 Downgrade TD Cowen Outperform → Market Perform
Aug-03-23 Downgrade Deutsche Bank Buy → Hold
Jul-24-23 Initiated William Blair Mkt Perform
Jul-14-23 Initiated HSBC Securities Reduce
Jun-26-23 Upgrade UBS Neutral → Buy
Apr-26-23 Initiated Guggenheim Neutral
Mar-13-23 Upgrade TD Cowen Market Perform → Outperform
Mar-02-23 Initiated RBC Capital Mkts Outperform
Feb-24-23 Downgrade SVB Securities Market Perform → Underperform
Dec-19-22 Upgrade Jefferies Hold → Buy
Dec-14-22 Downgrade Chardan Capital Markets Buy → Neutral
Oct-21-22 Upgrade SVB Leerink Underperform → Mkt Perform
Sep-08-22 Upgrade Deutsche Bank Hold → Buy
Feb-01-22 Upgrade Redburn Sell → Neutral
Jan-26-22 Upgrade Deutsche Bank Sell → Hold
Jan-21-22 Upgrade BofA Securities Underperform → Neutral
Jan-21-22 Initiated UBS Neutral
Dec-07-21 Initiated Cowen Market Perform
Nov-09-21 Initiated Wolfe Research Outperform
Oct-22-21 Initiated Deutsche Bank Sell
Oct-15-21 Upgrade Piper Sandler Neutral → Overweight
Aug-06-21 Downgrade Oppenheimer Outperform → Perform
Aug-06-21 Downgrade Piper Sandler Overweight → Neutral
Jul-15-21 Reiterated Jefferies Hold
Feb-01-21 Downgrade BofA Securities Neutral → Underperform
Dec-16-20 Downgrade Jefferies Buy → Hold
Dec-16-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Dec-09-20 Downgrade Needham Buy → Hold
Nov-23-20 Initiated Wells Fargo Equal Weight
Nov-17-20 Downgrade BMO Capital Markets Outperform → Market Perform
Sep-08-20 Downgrade SVB Leerink Mkt Perform → Underperform
Jul-23-20 Initiated SVB Leerink Mkt Perform
Jul-20-20 Downgrade JP Morgan Overweight → Neutral
Jul-13-20 Initiated Jefferies Buy
Jun-30-20 Initiated Argus Buy
Jun-08-20 Initiated Barclays Overweight
Apr-30-20 Initiated BMO Capital Markets Outperform
Mar-05-20 Downgrade BofA/Merrill Buy → Neutral
Dec-03-19 Resumed BofA/Merrill Buy
Oct-25-19 Initiated ROTH Capital Buy
Apr-05-19 Initiated Chardan Capital Markets Buy
View All

Moderna Inc Stock (MRNA) Latest News

pulisher
10:22 AM

Pediatrics group defies CDC and recommends COVID shots for kids - Seeking Alpha

10:22 AM
pulisher
04:58 AM

National Pension Service Decreases Stock Holdings in Moderna, Inc. $MRNA - MarketBeat

04:58 AM
pulisher
Aug 18, 2025

Invesco Ltd. Buys 877,162 Shares of Moderna, Inc. $MRNA - MarketBeat

Aug 18, 2025
pulisher
Aug 18, 2025

Moderna Fails To Block UPC Claims Against Subsidiaries - Law360

Aug 18, 2025
pulisher
Aug 18, 2025

mRNA Technology Market Is Booming So Rapidly | Pfizer, Moderna, BioNTech - openPR.com

Aug 18, 2025
pulisher
Aug 18, 2025

Blair William & Co. IL Trims Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Aug 18, 2025
pulisher
Aug 17, 2025

Who Owns Moderna? Biggest Shareholders and Recent Insider Trades - TIKR.com

Aug 17, 2025
pulisher
Aug 17, 2025

Charles Schwab Investment Management Inc. Grows Stock Holdings in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Aug 17, 2025
pulisher
Aug 17, 2025

Moderna (NASDAQ:MRNA) Trading Up 6.6%Time to Buy? - MarketBeat

Aug 17, 2025
pulisher
Aug 17, 2025

If You're in Your 30s, Consider Buying These 2 Healthcare Stocks - AOL.com

Aug 17, 2025
pulisher
Aug 17, 2025

Neuberger Berman Group LLC Grows Stock Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Aug 17, 2025
pulisher
Aug 17, 2025

Traders Buy High Volume of Moderna Call Options (NASDAQ:MRNA) - MarketBeat

Aug 17, 2025
pulisher
Aug 16, 2025

Moderna's flu vaccine shows positive late-stage trial results, paving way for combination Covid shot - MSN

Aug 16, 2025
pulisher
Aug 16, 2025

Stock Analysis | Moderna OutlookWeak Technicals and Mixed Market Signals - AInvest

Aug 16, 2025
pulisher
Aug 16, 2025

Moderna Inc Expands Beyond Respiratory Vaccines – Is Diversification the Key to Long-Term Success? - Smartkarma

Aug 16, 2025
pulisher
Aug 16, 2025

Moderna to lay off 10% of staff this year - MSN

Aug 16, 2025
pulisher
Aug 15, 2025

Moderna Inc's GF Score Indicates Potential Underperformance - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

Deutsche Bank AG Decreases Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Aug 15, 2025
pulisher
Aug 15, 2025

Moderna Stock Surges 4.98% as Trading Volume Jumps 70% to 402nd Market Activity Rank - AInvest

Aug 15, 2025
pulisher
Aug 15, 2025

A US FDA Move to Revoke Pfizer’s Pediatric COVID-19 Vaccine EUA Could Raise Supply Questions - insights.citeline.com

Aug 15, 2025
pulisher
Aug 15, 2025

Moderna to Cut 10% of Staff to Offset Slowing Covid Business - MSN

Aug 15, 2025
pulisher
Aug 15, 2025

Short bets on S&P 500 Healthcare sector ease in July; Moderna remains most heavily shorted stock - Seeking Alpha

Aug 15, 2025
pulisher
Aug 15, 2025

Moderna layoffs: U.S. Pharma giant announces massive job cuts, to have less than 5,000 employees, MRNA stocks sink - MSN

Aug 15, 2025
pulisher
Aug 15, 2025

Layoff Tracker: Bausch Health Closes California Site, Cuts 49 Employees - BioSpace

Aug 15, 2025
pulisher
Aug 14, 2025

Vanguard Group Inc. Buys 72,763 Shares of Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Aug 14, 2025
pulisher
Aug 14, 2025

ASR Vermogensbeheer N.V. Invests $614,000 in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Aug 14, 2025
pulisher
Aug 14, 2025

Mitsubishi UFJ Asset Management Co. Ltd. Raises Position in Moderna, Inc. (NASDAQ:MRNA) - MarketBeat

Aug 14, 2025
pulisher
Aug 14, 2025

Moderna’s SWOT analysis: mRNA pioneer faces pivotal year for stock By Investing.com - Investing.com Australia

Aug 14, 2025
pulisher
Aug 14, 2025

Moderna’s SWOT analysis: mRNA pioneer faces pivotal year for stock - Investing.com

Aug 14, 2025
pulisher
Aug 13, 2025

Rate Cut Rationale and Healthcare Gains: Evaluating the Surge in Biogen, Moderna, and Align Tech - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Biogen, Moderna, Align Technology, QuidelOrtho, and Masimo Shares Skyrocket, What You Need To Know - TradingView

Aug 13, 2025
pulisher
Aug 13, 2025

Moderna Stock Jumps as NIH Chief Tempers Administration’s Attack on mRNA - Barron's

Aug 13, 2025
pulisher
Aug 13, 2025

Notable Stocks Rise on August 13th: Paramount, Coinbase, Warner Bros., AMD, and Moderna Lead the Way. - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Is Moderna Stock A Sell After Cutting Its Sales Outlook — Again? - Investor's Business Daily

Aug 13, 2025
pulisher
Aug 13, 2025

Multi Factor Analysis Ranks Moderna Inc. as Strong BuyShare Buyback & Free Safe Entry Trade Signal Reports - 선데이타임즈

Aug 13, 2025
pulisher
Aug 13, 2025

UK Court of Appeal Confirms Moderna’s EP’949 Patent is Valid and Infringed by Pfizer/BioNTech - Democrat and Chronicle

Aug 13, 2025
pulisher
Aug 13, 2025

3 Reasons to Avoid MRNA and 1 Stock to Buy Instead - Yahoo Finance

Aug 13, 2025
pulisher
Aug 13, 2025

The 5 Most Interesting Analyst Questions From Moderna’s Q2 Earnings Call - Yahoo Finance

Aug 13, 2025
pulisher
Aug 12, 2025

Other Nations Move Toward Making Their Own Vaccines as US Cuts Funding - Bloomberg.com

Aug 12, 2025
pulisher
Aug 12, 2025

Moderna's COVID-19 Vaccine Faces Regulatory Threats, RSV Vaccine Sales Uncertain, and Clinical Programs in Development - AInvest

Aug 12, 2025
pulisher
Aug 12, 2025

Moderna, Teleflex, Envista, Enovis, and UnitedHealth Shares Are Soaring, What You Need To Know - Yahoo Finance

Aug 12, 2025
pulisher
Aug 12, 2025

CDC Shooting Linked To Suspect's COVID-19 Vaccine Beliefs, Former Staff Blame RFK Jr. Hostility Toward Agency - Benzinga

Aug 12, 2025
pulisher
Aug 12, 2025

KDCA readies mRNA vaccines, tech for COVID-19, future outbreaks - BioWorld MedTech

Aug 12, 2025
pulisher
Aug 12, 2025

FDA Weighs Pulling Pfizer’s Covid Vaccine for Kids Under Age 5 - Bloomberg.com

Aug 12, 2025
pulisher
Aug 12, 2025

Moderna, Inc. (MRNA)’s “Got The Double Whammy,” Says Jim Cramer - MSN

Aug 12, 2025
pulisher
Aug 12, 2025

Day 5 of Loss Streak for Moderna Stock with -7.9% Return (vs. -39% YTD) [8/11/2025] - Trefis

Aug 12, 2025
pulisher
Aug 11, 2025

Moderna, Inc. (MRNA) stock price, news, quote and history - uk.finance.yahoo.com

Aug 11, 2025
pulisher
Aug 11, 2025

FDA May Not Renew Pfizer's Authorization For Covid Shots In Younger Children, Moderna Prepares To Boost Supply - Benzinga

Aug 11, 2025
pulisher
Aug 11, 2025

mRNA patent wars kick into higher gear during dog days of summer - JUVE Patent

Aug 11, 2025
pulisher
Aug 11, 2025

Global and U.S. Personalized Cancer Vaccines Market Generated - openPR.com

Aug 11, 2025
pulisher
Aug 11, 2025

Global Cancer Vaccines Market to Surpass USD 15.00 Billion by 2032, Unlocking Over USD 10 Billion in New Growth Opportunities | MarketsandMarkets™. - GlobeNewswire Inc.

Aug 11, 2025

Moderna Inc Stock (MRNA) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$35.83
price down icon 0.33%
$85.51
price up icon 0.78%
$25.34
price down icon 3.70%
$112.61
price down icon 0.02%
$128.17
price up icon 0.62%
biotechnology ONC
$315.47
price down icon 1.19%
Cap:     |  Volume (24h):